Abstract
Updates to the NCCN Guidelines for Prostate Cancer include further refinements in taking a family history, new recommendations for germline and somatic testing, use of androgen receptor blockers for nonmetastatic castration-resistant prostate cancer, advice regarding intermittent versus continuous androgen deprivation therapy, and consideration of whether to treat the primary tumor in men diagnosed with de novo metastatic prostate cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 583-586 |
| Number of pages | 4 |
| Journal | Journal of the National Comprehensive Cancer Network : JNCCN |
| Volume | 17 |
| Issue number | 55 |
| DOIs | |
| State | Published - May 1 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'NCCN Guidelines Updates: Management of Prostate Cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS